These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
429 related items for PubMed ID: 29084048
1. Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair. Lee PJ, McNulty S, Duncavage EJ, Heusel JW, Hagemann IS. Int J Gynecol Pathol; 2018 Nov; 37(6):581-589. PubMed ID: 29084048 [Abstract] [Full Text] [Related]
2. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair]. Zhang YH, Wu HW, Wang J, Liang ZY. Zhonghua Bing Li Xue Za Zhi; 2021 May 08; 50(5):470-475. PubMed ID: 33915653 [Abstract] [Full Text] [Related]
3. [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer]. Tang XJ, Yang MY, Zhu LZ, Xu D, Yuan Y. Zhonghua Zhong Liu Za Zhi; 2021 Oct 23; 43(10):1088-1093. PubMed ID: 34695900 [Abstract] [Full Text] [Related]
4. MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome. Nelson GS, Pink A, Lee S, Han G, Morris D, Ogilvie T, Duggan MA, Köbel M. Gynecol Oncol; 2013 Nov 23; 131(2):309-14. PubMed ID: 23938375 [Abstract] [Full Text] [Related]
8. Performance of the Idylla microsatellite instability test in endometrial cancer. Mendiola M, Heredia-Soto V, Ruz-Caracuel I, Baillo A, Ramon-Patino JL, Berjon A, Escudero FJ, Pelaez-Garcia A, Hernandez A, Feliu J, Hardisson D, Redondo A. Mol Cell Probes; 2024 Oct 23; 77():101976. PubMed ID: 39069012 [Abstract] [Full Text] [Related]
9. Frequent CTNNB1 or PIK3CA Mutations Occurred in Endometrial Endometrioid Adenocarcinoma With High Levels of Microsatellite Instability and Loss of MSH2/MSH6 Expression. Huang HN, Kuo CW, Lin MC, Mao TL, Kuo KT. Appl Immunohistochem Mol Morphol; 2020 Apr 23; 28(4):284-289. PubMed ID: 30789355 [Abstract] [Full Text] [Related]
10. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases]. Liu Y, Guo YH, Luo Y, Sun L, Zhao S, Shao B, Zang FL, Qiu ZQ, Sun BC, Sun Y. Zhonghua Bing Li Xue Za Zhi; 2021 Apr 08; 50(4):369-375. PubMed ID: 33831997 [Abstract] [Full Text] [Related]
11. Lack of association between deficient mismatch repair expression and outcome in endometrial carcinomas of the endometrioid type. Ruiz I, Martín-Arruti M, Lopez-Lopez E, Garcia-Orad A. Gynecol Oncol; 2014 Jul 08; 134(1):20-3. PubMed ID: 24814467 [Abstract] [Full Text] [Related]
12. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset. Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA. Am J Surg Pathol; 2009 Dec 08; 33(12):1869-77. PubMed ID: 19898223 [Abstract] [Full Text] [Related]
19. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population? Kahn RM, Gordhandas S, Maddy BP, Baltich Nelson B, Askin G, Christos PJ, Caputo TA, Chapman-Davis E, Holcomb K, Frey MK. Cancer; 2019 Sep 15; 125(18):3172-3183. PubMed ID: 31150123 [Abstract] [Full Text] [Related]
20. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Lagerstedt-Robinson K, Rohlin A, Aravidis C, Melin B, Nordling M, Stenmark-Askmalm M, Lindblom A, Nilbert M. Oncol Rep; 2016 Nov 15; 36(5):2823-2835. PubMed ID: 27601186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]